Switch to:

Cancer Drug Preauthorization List Expanded in August

Switch to:

Cancer Drug Preauthorization List Expanded in August

07/20/2021

Starting Aug. 15, 2021, ConnectiCare and EmblemHealth will require preauthorization for additional oncology-related chemotherapeutic drugs and supportive agents when delivered in the physician’s office, outpatient hospital, or other ambulatory setting. See ConnectiCare’s Pharmacy Policies and EmblemHealth’s Frequently Asked Questions: EmblemHealth Oncology Drug Management to determine where to submit the preauthorization request.

provider

Access the ConnectiCare Portal

Language Assistance:

Any information provided on this Website is for informational purposes only. It is not medical advice and should not be substituted for regular consultation with your health care provider. If you have any concerns about your health, please contact your health care provider's office.

Also, this information is not intended to imply that services or treatments described in the information are covered benefits under your plan. Please refer to your Membership Agreement, Certificate of Coverage, Benefit Summary, or other plan documents for specific information about your benefits coverage.